Tan Y - Search Results

1

A rare case of spindle cell neoplasm with NTRK-fusion in central nervous system.

Gong H, Gao K, Mao P, Ma S, Zhao D, Bian Y, Liu R, Gao L, Duan Q, Zhang Q, Tan Y, Wang T. Gong H, et al. Among authors: tan y. Pathol Int. 2023 Jan;73(1):52-54. doi: 10.1111/pin.13260. Epub 2022 Jul 28. Pathol Int. 2023. PMID: 35900013 No abstract available.

2

Case Report: A Pancreatic Ductal Adenocarcinoma Patient With Concurrent Targetable Somatic Novel KANK1-ALK, UPP2-NTRK3 Fusion, and Pathogenetic Germline BRCA Mutation.

Meng F, Lu L, Tan Y, Duan Q, Lu H. Meng F, et al. Among authors: tan y. Front Oncol. 2021 Oct 4;11:757965. doi: 10.3389/fonc.2021.757965. eCollection 2021. Front Oncol. 2021. PMID: 34671564 Free PMC article.

3

Identification of IGF1R mutation as a novel predictor of efficacious immunotherapy in melanoma.

Ma D, Zhang Q, Duan Q, Tan Y, Sun T, Qi C, Qin Y, Liu H. Ma D, et al. Among authors: tan y. J Transl Med. 2022 Apr 11;20(1):172. doi: 10.1186/s12967-022-03324-8. J Transl Med. 2022. PMID: 35410220 Free PMC article. No abstract available.

4

Case Report: A Lung Adenocarcinoma With Brain Metastasis Harbored Novel MET 14 Skipping Alteration Sensitive to Savolitinib.

Li J, Feng Y, Tan Y, Duan Q, Zhang Q. Li J, et al. Among authors: tan y. Front Oncol. 2022 Apr 4;12:863560. doi: 10.3389/fonc.2022.863560. eCollection 2022. Front Oncol. 2022. PMID: 35444936 Free PMC article.

5

A lung adenocarcinoma patient harboring MET c. 3028 + 2 T >A variant sensitive to crizotinib treatment.

Jiang R, Wei D, Tan Y, Duan Q. Jiang R, et al. Among authors: tan y. Invest New Drugs. 2022 Aug;40(4):870-873. doi: 10.1007/s10637-022-01252-4. Epub 2022 May 12. Invest New Drugs. 2022. PMID: 35551560

6

Dramatic response to alectinib in a lung adenocarcinoma patient harboring a Novel SSFA2-ALK fusion.

Lin X, Yang X, Tan Y, Duan Q, He M. Lin X, et al. Among authors: tan y. Invest New Drugs. 2022 Oct;40(5):1160-1163. doi: 10.1007/s10637-022-01260-4. Epub 2022 May 24. Invest New Drugs. 2022. PMID: 35608716

7

Molecular and Clinicopathological Characteristics of Lung Cancer Concomitant Chronic Obstructive Pulmonary Disease (COPD).

Ma H, Zhang Q, Zhao Y, Zhang Y, Zhang J, Chen G, Tan Y, Zhang Q, Duan Q, Sun T, Qi C, Li F. Ma H, et al. Among authors: tan y. Int J Chron Obstruct Pulmon Dis. 2022 Jul 14;17:1601-1612. doi: 10.2147/COPD.S363482. eCollection 2022. Int J Chron Obstruct Pulmon Dis. 2022. PMID: 35860812 Free PMC article.

8

NOTCH4 mutation as predictive biomarker for immunotherapy benefits in NRAS wildtype melanoma.

Li H, Zhang Q, Duan Q, Tan Y, Sun T, Qi C. Li H, et al. Among authors: tan y. Front Immunol. 2022 Jul 29;13:894110. doi: 10.3389/fimmu.2022.894110. eCollection 2022. Front Immunol. 2022. PMID: 35967450 Free PMC article.

9

MET inhibitors for MET amplification-What's the most appropriate detection method and cut-off value?

Zhang L, Tan Y, Duan Q. Zhang L, et al. Among authors: tan y. Lung Cancer. 2022 Dec;174:172-173. doi: 10.1016/j.lungcan.2022.08.005. Epub 2022 Aug 12. Lung Cancer. 2022. PMID: 35985889 No abstract available.

10

MED12 mutation as a potential predictive biomarker for immune checkpoint inhibitors in pan-cancer.

Zhou Y, Tan Y, Zhang Q, Duan Q, Chen J. Zhou Y, et al. Among authors: tan y. Eur J Med Res. 2022 Oct 29;27(1):225. doi: 10.1186/s40001-022-00856-z. Eur J Med Res. 2022. PMID: 36309740 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,970 results

Search Page

Filters